Skip to main content
. 2022 Jun 16;17(6):e0269608. doi: 10.1371/journal.pone.0269608

Table 3. Results groups for participation scores.

hEDS/ HSD CG1 FM1 cEDS/ vEDS CG2 FM2 hEDS HSD MD Sig.
Overall participation score (SD) (N = 41) (N = 41) (N = 47) (N = 18) (N = 18) (N = 22) (N = 18) (N = 23)
44,58 (9,76) 55,66 (10.54) -11.09 .000*
52.20 (12.41) 56.76 (12.13) -4,56 .305
44,58 (9,76) 43.48 (10.34) 1.09 .615
44.47 (8.49) 44.66 (10.85) -0.19 .951
44.58 (9.76) 52.20 (12.41) -7.62 .014*
52.20 (12.41) 46,82 (12.13) 5.37 .176
Self-performed activities (SD) (N = 47) (N = 47) (N = 47) (N = 22) (N = 22) (N = 22) (N = 20) (N = 27)
54.79 (15.05) 60.74 (11.20) -5.94 .026*
60.19 (14.41) 62.36 (12.85) -2.17 .618
54.79 (15.05) 53.24 (13.72) 1.55 .601
53.50 (15.16) 55.76 (15.18) -2.26 .617
54.79 (15.05) 60.19 (14.41) -5.40 .164
60.19 (14.41) 53.40 (13.02) 6.78 .109
‘Self-performed activities in accordance with personal choices and wishes’ (SD) (N = 47) (N = 47) (N = 47) (N = 22) (N = 22) (N = 22) (N = 20) (N = 27)
55.71 (14.43) 66.78 (10.47) -11.08 .001*
61.25 (14.17) 61.20 (14.47) 0.04 .993
55.71 (14.43) 57.74 (13.28) -2.03 .480
54.37 (14.66) 56.70 (14.46) -2.33 .590
55.71 (14.43) 61.25 (14.17) -5.54 .140
61.25 (14.17) 58.17 (14.71) 3.07 .484
‘Self-performed activities leading to appreciation and social acceptance’ (SD) (N = 47) (N = 47) (N = 47) (N = 22) (N = 22) (N = 22) (N = 20) N = 27)
53.66 (16.64) 66.79 (10.47) -13.13 .000*
58.87 (15.26) 61.20 (14.47) -2.34 .643
53.66 (16.64) 57.74 (13.28) -4.08 .192
52.44 (16.99) 54.60 (16.63) -2.16 .665
53.66 (16.64) 58.87 (15.26) -5.20 .219
58.87 (15.26) 58.17 (14.71) 0.70 .154
‘Delegated activities’ (N = 41) (N = 41) (N = 18) (N = 18) (N = 18) (N = 23)
38.76 (10.90) 57.94 (18.28) -19.18 .000*
51.30 (17.76) 56.96 (16.67) -5.76 .396
38.76 (10.90) 37.57 (13.57) 1.19 .653
39.42 (10.57) 38.24 (11.36) 1.18 .736
38.76 (10.90) 51.30 (17.76) -12.53 .011*
51.30 (17.76) 46.00 (22.36) 5.29 .420

N: number of participants; SD: standard deviation; MD: mean difference; CG1: control group one; CG2: control group 2; FM1: fibromyalgia group 1; FM2: fibromyalgia group 2

*: significance at a level of .05